A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan

被引:0
|
作者
Takumi Hirata
Daisuke Sugiyama
Shin-ya Nagasawa
Yoshitaka Murakami
Shigeyuki Saitoh
Akira Okayama
Hiroyasu Iso
Fujiko Irie
Toshimi Sairenchi
Yoshihiro Miyamoto
Michiko Yamada
Shizukiyo Ishikawa
Katsuyuki Miura
Hirotsugu Ueshima
Tomonori Okamura
机构
[1] Keio University School of Medicine,Center for Supercentenarian Medical Research
[2] Keio University School of Medicine,Department of Preventive Medicine and Public Health
[3] Kanazawa Medical University,Department of Epidemiology and Public Health
[4] Toho University,Division of Medical Statistics, Department of Social Medicine, Faculty of Medicine
[5] Sapporo Medical University School of Health Sciences,Department of Nursing
[6] Research Institute of Strategy for Prevention,Department of Social and Environmental Medicine
[7] Osaka University Graduate School of Medicine,Department of Health and Welfare
[8] Ibaraki Prefectural Office,Department of Public Health
[9] Dokkyo Medical University School of Medicine,Department of Preventive Medicine and Epidemiologic Informatics
[10] National Cerebral and Cardiovascular Center,Department of Clinical Studies
[11] Radiation Effects Research Foundation,Center for Community Medicine
[12] Jichi Medical University,Department of Public Health
[13] Shiga University of Medical Science,Center for Epidemiologic Research in Asia
[14] Shiga University of Medical Science,undefined
来源
关键词
Cardiovascular diseases; Epidemiology; High-density lipoprotein cholesterol; Mortality;
D O I
暂无
中图分类号
学科分类号
摘要
Low levels of serum high-density lipoprotein cholesterol (HDL-C) have been shown to be associated with increased risk of coronary heart disease (CHD). However, because this is usually observed in the context of other lipid abnormalities, it is not known whether isolated low serum HDL-C levels are an independent risk factor for CHD. We performed a large pooled analysis in Japan using data from nine cohorts with 41,206 participants aged 40–89 years who were free of cardiovascular disease at baseline. We divided participants into three groups: isolated low HDL-C, non-isolated low HDL-C, and normal HDL-C. Cohort-stratified Cox proportional hazards models were used to estimate multivariate-adjusted hazard ratios (HRs) for death due to CHD, ischemic stroke, and intracranial cerebral hemorrhage; during a 12.9-year follow-up, we observed 355, 286, and 138 deaths, respectively, in these groups. Non-isolated low HDL-C was significantly associated with increased risk of CHD compared with normal HDL-C (HR 1.37, 95 % confidence interval (CI) 1.04–1.80); however, isolated low HDL-C was not. Although isolated low HDL-C was significantly associated with decreased risk of CHD (HR 0.51, 95 % CI 0.29–0.89) in women, it was significantly associated with increased risk of intracranial cerebral hemorrhage in all participants (HR 1.62, 95 % CI 1.04–2.53) and in men (HR 2.00, 95 % CI 1.04–3.83). In conclusion, isolated low HDL-C levels are not associated with increased risk of CHD in Japan. CHD risk may, therefore, be more strongly affected by serum total cholesterol levels in this population.
引用
收藏
页码:547 / 557
页数:10
相关论文
共 50 条
  • [31] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL ANALYSIS
    WHITEHEAD, TP
    BULLOCK, DG
    CARTER, TJN
    CLINICAL CHEMISTRY, 1979, 25 (12) : 2055 - 2056
  • [32] Case 2: A patient with low levels of high-density lipoprotein cholesterol
    Friedewald, VE
    Gotto, AM
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (03): : 403 - 403
  • [33] Low serum levels of high-density lipoprotein cholesterol and hypolipidaemic treatment
    Kolovou, GD
    Cokkinos, DV
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (05) : 265 - 268
  • [34] Aspirin resistance is related to high-density lipoprotein cholesterol levels and total cholesterol/high-density lipoprotein ratio
    Coma-Canella, I
    Cordero, A
    Velasco, A
    Azcárate, P
    Castaño, S
    Palazuelos, J
    Martín, D
    Mejía, S
    EUROPEAN HEART JOURNAL, 2003, 24 : 370 - 370
  • [35] Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
    Hausenloy, D. J.
    Yellon, D. M.
    HEART, 2008, 94 (06) : 706 - 714
  • [36] Increasing high-density lipoprotein cholesterol levels for cardiovascular benefit: The end of a dream?
    Pirillo, Angela
    Catapano, Alberico Luigi
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (05) : 531 - 532
  • [37] Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk?
    Dean, BB
    Borenstein, JE
    Henning, JM
    Knight, K
    Merz, CNB
    AMERICAN HEART JOURNAL, 2004, 147 (06) : 966 - 976
  • [38] Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
    Tian, Li
    Liu, Yinghui
    Qin, Yang
    Long, Shiyin
    Xu, Yanhua
    Fu, Mingde
    LIPIDS IN HEALTH AND DISEASE, 2010, 9
  • [39] Very High Levels of High-Density Lipoprotein Cholesterol and Cardiovascular Events in Japanese Population
    Masuda, Daisaku
    Yamashita, Shizuya
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (07) : 771 - 772
  • [40] Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
    Li Tian
    Yinghui Liu
    Yang Qin
    Shiyin Long
    Yanhua Xu
    Mingde Fu
    Lipids in Health and Disease, 9